Evidence map›Paper›PMID 42463634›Full record

ArticleACS applied materials & interfaces2026

Unveiling the Printability and Performance of 3D Printed Ethylene-Vinyl Acetate Stretchable Foams.

Nariman Rajabifar, Amir Ameli

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Nariman RajabifarDepartment of Plastics Engineering, University of Massachusetts Lowell, 1 University Avenue, Lowell, Massachusetts01854, United States.
Amir AmeliDepartment of Plastics Engineering, University of Massachusetts Lowell, 1 University Avenue, Lowell, Massachusetts01854, United States.ORCID 0000-0002-1616-1162

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rise of additive manufacturing has pivoted the trajectory of advanced materials with intricate geometries and precise design. Although various materials have been adapted to 3D printing, developing printable microcellular foams remains in its infancy. Herein, for the first time, we report 3D printed ethylene-vinyl acetate (EVA) foams enabled by expandable microspheres (EMs). Expandable filaments of EVA/EMs containing 0-10 wt % EM result in a tailored density in the range of 0.903-0.224 g/cm3. The viable temperature spectrum relies upon EM content, where higher EM loading leads to a wider printing window. The foam density further exhibits an optimal correlation with temperature, reaching its minimum at 230 °C, independent of EM content. Microstructural analyses reveal uniform morphologies wherein the foam's cell density increases and cell size slightly drops with EM loading. The decay rate of Young's modulus and tensile strength with density reduction is significantly lower compared to conventional foams, which is attributed to the reinforcing effect of the EM shell material. Strain rate and print pattern dependency of mechanical properties are also discussed. While unfoamed EVA exhibits strain hardening upon cyclic compressive loading, the addition of EMs introduces a counteracting strain-softening behavior proportional to EM content. The thermal analysis furthermore depicts that EM leaves a negligible impact on the crystallinity of EVA. The findings of this work highlight the potential of 3D printed EVA foams as lightweight and tunable materials for various applications.

Indexed as

advanced materialsdeformation mechanismsEVA foam 3D printingmechanical propertiesstructure−property relationships

Identifiers

PMID42463634
PMCPMC13425563

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.